Načítá se...

Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer.

OBJECTIVE:To evaluate the efficacy and safety of gemcitabine (GEM) at 30 min standard-dose infusion (30 min-SDI) compared with prolonged low-dose infusion (P-LDI) in patients with advanced non-small-cell lung cancer (NSCLC). METHODS:Electronic databases including Pubmed, EMbase, Cochrane Library, CN...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhao Dehua, Chu Mingming, Wang Jisheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science (PLoS) 2018-01-01
Edice:PLoS ONE
On-line přístup:http://europepmc.org/articles/PMC5862432?pdf=render
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!